CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Galenica AG Company Snapshot
Galenica AG operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galenica AG with three other drug stores in Europe: Selcuk Ecza Deposu Ticaret ve Sanayi AS of Turkey (2016 sales of 8.64 billion Turkish Liras [US$2.39 billion] of which 100% was Medical and Hospital Equipment), Neuca SA of Poland (7.08 billion Polish New Zlotys [US$1.79 billion] of which 99% was Pharmaceutical Wholesale), and Pelion SA which is also based in Poland (9.18 billion Polish New Zlotys [US$2.33 billion] ).

Sales Analysis. Galenica AG reported sales of 4.12 billion Swiss Francs (US$4.16 billion) for the year ending December of 2016. This represents an increase of 8.6% versus 2015, when the company's sales were 3.79 billion Swiss Francs. Sales at Galenica AG have increased during each of the previous five years (and since 2011, sales have increased a total of 29%). Sales of Vifor Pharma saw an increase that was more than double the company's growth rate: sales were up 20.7% in 2016, from 967.02 million Swiss Francs to 1.17 billion Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Galenica AG
  Stock Performance Chart for Galenica AG
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 1,080.00
(Figures in Swiss Francs)
1 Week -9.8%   13 Weeks -6.0%  
4 Weeks -5.3%   52 Weeks -23.5%  
 
Galenica AG Key Data:
  Ticker: GALN Country: Switzerland
  Exchanges: GVA OTH ZHR Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 4,118,370,000
(Year Ending Jan 2017).
Employees: 8,661
  Currency: Swiss Francs Market Cap: 6,995,196,720
  Fiscal Yr Ends: December Shares Outstanding: 6,477,034
  Share Type: Namenaktie Closely Held Shares: 1,859,500
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.